Skip to main content

China-related matters · Research first

For lawyers/Contact/Log in
China Legal PortalResearch · Routes · Counsel
Ask a lawyer

Search the portal

Legal signal newsroom

What changed—and why it matters for China-connected work.

Dated analysis of legal developments. Recency is not automatically importance: the lead pieces below are editorially selected for practical impact.

Browse the archive Evergreen national guides
Selected analysisEditorial

Real Property

Foreign Investment in Forestry Land Development and Urban Renewal in China: A Legal Guide for International Investors

Under China's Constitution and Land Administration Law, all land in China is either state-owned or collectively owned. Forestland in Heilongjiang is predomin…

Read featured analysis →
01Editorially selectedPractical impact before publishing order.
02Published vs updatedDates map to verified content fields.
03Bridge to evergreen researchInsights lead back to durable guides.

Archive dispatches

Latest legal signals

12 analyses on this page.

Life Sciences
Legally reviewed · 8 Aug 2026

Two-Invoice Pressure After VBP: Redesigning Pharma Device Channels Without Building a Paper CSO

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Academic Conference Speaker Fees in China Healthcare: An FMV File That Survives Scrutiny

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Internet Hospital KOL Scripts: Medical-Legal Approval Before the Livestream Goes Live

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

China Drug Patent Linkage: Building a Category-Style Challenge Watch for Originators

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Implant Fracture Claims in China: Dual-Track Appraisal Strategy for Manufacturers

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CDMO Batch Failure in China: Who Pays for Destroyed Product, Delay, and Lost Launch Windows

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Medical Device Design-Around in China: FTO Notes That Engineering Will Actually Use

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

PI Protocol Deviations in China Trials: Splitting Sponsor, Hospital, and Investigator Risk

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Royalty Audits on China License Deals: When Sales Live in WeChat and Tender Files

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

One-Page Dawn Raid Card for Pharma Sales & Medical Affairs Teams

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

FDA Warning Letter with a China Site: Run US CAPA and PRC Legal Tracks Together

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

VBP Award Day +14: The Distributor Contract Heat-Map In-House Counsel Actually Needs

8 min readRead analysis →

Signal to framework

A development is useful only when you can place it in the wider legal framework.

Use the national guides for the durable architecture behind a news event, then return here when a development changes the practical question.

Explore legal guides →